ALVO

Alvotech
ALVO

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$2.52B
EV
$3.66B
Shares Outstanding
301.81M
Beta
-0.05

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$18.00
P/E 2025E
30.31x
P/Revenue 2025E
3.93x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Alvotech

gainify
ALVO

Alvotech

ALVO

Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company’s lead program is AVT02, a high con...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Wessman, Robert

Employees

1,012

IPO Date

2022-06-16

Headquarters

9, Rue de Bitbourg, Luxembourg City 1273, Luxembourg

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved